Home
About
Solutions
Early detection of cancers
Phenotypic drug discovery
Phenotypic drug discovery strategy
Drug Safety
Drug-induced liver injury (DILI) detection
Idiosyncratic drug-induced liver injury (iDILI) detection
Drug efficacy
HCC model for small molecules targeted therapy
HCC model for adoptive cell therapy
Products for r&d
OneSmartDiff: a one step immune cell diffentation medium
News
Publications / Brochures
Menu
Home
About
Solutions
Early detection of cancers
Phenotypic drug discovery
Phenotypic drug discovery strategy
Drug Safety
Drug-induced liver injury (DILI) detection
Idiosyncratic drug-induced liver injury (iDILI) detection
Drug efficacy
HCC model for small molecules targeted therapy
HCC model for adoptive cell therapy
Products for r&d
OneSmartDiff: a one step immune cell diffentation medium
News
Publications / Brochures
Jour :
28 mars 2024
Detection of idiosyncratic drug-induced liver injury (iDILI) with theGenuineSelect-TOX system
Home
About
Solutions
Early detection of cancers
Phenotypic drug discovery
Phenotypic drug discovery strategy
Drug Safety
Drug-induced liver injury (DILI) detection
Idiosyncratic drug-induced liver injury (iDILI) detection
Drug efficacy
HCC model for small molecules targeted therapy
HCC model for adoptive cell therapy
Products for r&d
OneSmartDiff: a one step immune cell diffentation medium
News
Publications / Brochures
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.
OK
Non
Politique de confidentialité
